首页> 外文期刊>British Journal of Clinical Pharmacology >Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
【24h】

Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.

机译:地高辛和通便聚合物聚乙二醇4000在健康志愿者中的药代动力学和药效学药物相互作用。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: The aim of this study was to examine the bioequivalence between a single oral dose of digoxin administered alone and with a coadministration of macrogol 4000 (a laxative polymer) in 18 healthy volunteers. METHODS: This was an open, randomised, two-way cross-over study, with a single dose oral administration of 0.5 mg digoxin administered alone or in combination with macrogol 4000, 20 g day-1 during 8 days. Pharmacokinetics of digoxin, heart rate and PR ECG interval at rest were assessed. RESULTS: Macrogol 4000 coadministration was associated with a 30% decrease of digoxin AUC and a 40% decrease in its Cmax (P<0.05). Digoxin tmax and t1/2,z were not significantly altered. Heart rate and PR interval did not differ during the two therapeutic sequences, digoxin alone and digoxin in combination. CONCLUSIONS: Macrogol 4000 coadministration interacts with single-dose digoxin pharmacokinetics. This is most likely due to a reduction of the intestinal absorption of digoxin. However, there was no consequence of this interaction on heart rate and AV conduction.
机译:目的:本研究的目的是在18名健康志愿者中检查单次口服地高辛与大剂量4000聚乙二醇(泻药)共同给药之间的生物等效性。方法:这是一项开放,随机,双向研究,单剂量口服0.5 mg地高辛或与macrogol 4000一起口服0.5 mg地高辛,为期8天,每次20 g。评估了地高辛,静息时心率和PR ECG间隔的药代动力学。结果:Macrogol 4000共同给药与地高辛AUC降低30%和其Cmax降低40%相关(P <0.05)。地高辛的tmax和t1 / 2,z没有明显改变。在单独使用地高辛和联合使用地高辛这两个治疗序列期间,心率和PR间隔无差异。结论:Macrogol 4000共同给药与单剂量地高辛药代动力学相互作用。这很可能是由于地高辛的肠道吸收减少所致。但是,这种相互作用对心率和AV传导没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号